These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12419562)

  • 1. Effects of lipids on thrombotic mechanisms in atherosclerosis.
    Tousoulis D; Davies G; Ambrose J; Tentolouris C; Stefanadis C; Toutouzas P
    Int J Cardiol; 2002 Dec; 86(2-3):239-47. PubMed ID: 12419562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between atherosclerosis and thrombosis.
    Loscalzo J
    Circulation; 1992 Dec; 86(6 Suppl):III95-9. PubMed ID: 1424055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque.
    Rabbani LE; Loscalzo J
    Atherosclerosis; 1994 Jan; 105(1):1-7. PubMed ID: 8155083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipids and atherosclerosis].
    Gmiński J
    Wiad Lek; 1996; 49(7-12):153-8. PubMed ID: 9245111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interface of atherosclerosis and thrombosis: basic mechanisms.
    Libby P
    Vasc Med; 1998; 3(3):225-9. PubMed ID: 9892515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].
    Drouet L; Mazoyer E; Bal dit Sollier C; Hainaud P; Ripoll L
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():41-51. PubMed ID: 9833079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic risk factors for atherosclerosis.
    Dobroski DR; Loscalzo J
    Coron Artery Dis; 1996 Dec; 7(12):919-32. PubMed ID: 9116935
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of lipids and lipoproteins on thrombosis and rheology.
    Rosenson RS; Lowe GD
    Atherosclerosis; 1998 Oct; 140(2):271-80. PubMed ID: 9862270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostasis and atherosclerosis.
    Warkentin TE
    Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
    Fuster V; Stein B; Ambrose JA; Badimon L; Badimon JJ; Chesebro JH
    Circulation; 1990 Sep; 82(3 Suppl):II47-59. PubMed ID: 2203564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
    Pearson TA; LaCava J; Weil HF
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1674S-1682S. PubMed ID: 9129509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple mechanisms of thrombosis complicating atherosclerotic plaques.
    Libby P
    Clin Cardiol; 2000 Nov; 23 Suppl 6(Suppl 6):VI-3-7. PubMed ID: 11129684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of haemostatic factors, arteriosclerosis and cardiovascular disease.
    Haverkate F
    Vascul Pharmacol; 2002 Aug; 39(3):109-12. PubMed ID: 12616975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
    Smith EB
    Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombogenic factors and recurrent coronary events.
    Moss AJ; Goldstein RE; Marder VJ; Sparks CE; Oakes D; Greenberg H; Weiss HJ; Zareba W; Brown MW; Liang CS; Lichstein E; Little WC; Gillespie JA; Van Voorhees L; Krone RJ; Bodenheimer MM; Hochman J; Dwyer EM; Arora R; Marcus FI; Watelet LF; Case RB
    Circulation; 1999 May; 99(19):2517-22. PubMed ID: 10330382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis and atherosclerosis.
    Holvoet P; Collen D
    Curr Opin Lipidol; 1997 Oct; 8(5):320-8. PubMed ID: 9335957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms modifying atherosclerotic disease - from lipids to vascular biology.
    Weissberg P
    Atherosclerosis; 1999 Sep; 147 Suppl 1():S3-10. PubMed ID: 10575056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters.
    Hernández LR; Lundberg U; Arocha-Piñango CL
    Thromb Res; 2000 Aug; 99(3):295-305. PubMed ID: 10942796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.